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Summary
Multicellular organisms initiate adaptive responses when oxygen (O2) availability decreases, but the underlying mechanism
of O2 sensing remains elusive. We find that functionality of complex III of the mitochondrial electron transport chain (ETC)
is required for the hypoxic stabilization of HIF-1α and HIF-2α and that an increase in reactive oxygen species (ROS) links
this complex to HIF-α stabilization. Using RNAi to suppress expression of the Rieske iron-sulfur protein of complex III,
hypoxia-induced HIF-1α stabilization is attenuated, and ROS production, measured using a novel ROS-sensitive FRET
probe, is decreased. These results demonstrate that mitochondria function as O2 sensors and signal hypoxic HIF-1α and
HIF-2α stabilization by releasing ROS to the cytosol.Introduction
Multicellular organisms require oxygen (O2) for respiration and
respond to decreases in O2 availability (Bunn and Poyton,
1996) by activating transcriptional responses that preserve tis-
sue O2 supply and increase glycolytic capacity. Hypoxia-induc-
ible factors HIF-1 and -2 are the principal factors mediating
these changes. HIFs are heterodimers consisting of O2-regu-
lated (HIF-α) and constitutively expressed (HIF-β/ARNT) sub-
units (Kallio et al., 1997; Wang and Semenza, 1995). HIF-α is
degraded under normoxia following proline hydroxylation by
prolyl hydroxylases (PHDs; Jaakkola et al., 2001; Ivan et al.,
2001). This facilitates its recognition by VHL protein, an E3
ubiquitin ligase (Maxwell et al., 1999; Huang et al., 1998). Hyp-
oxia inhibits HIF-α hydroxylation, thereby allowing it to accu-
mulate, interact with ARNT, and initiate transcription (Berra et
al., 2003).
The O2 sensor responsible for inhibiting HIF-α degradation
during hypoxia is not established. PHDs require O2 as a sub-
strate and exhibit a relatively high Km for O2 in vitro (Hirsilae et
al., 2003), so it has been proposed that PHDs function as O2
sensors because the decreasing availability of O2 during hyp-
oxia could limit their ability to hydroxylate HIF (Hagen et al.,
2003; Epstein et al., 2001).
We propose that mitochondria function as O2 sensors and
signal hypoxia by releasing ROS to the cytosol (Chandel et al.,
1998; Chandel et al., 2000). The resulting oxidant signal then
mediates an inhibition of PHDs, leading to HIF-α stabilization.
This mitochondrial model has been controversial because pre-
vious studies relied on pharmacological tools, because con-
flicting reports have appeared (Vaux et al., 2001; Srinivas et al.,
2001) and because technical concerns have arisen regarding
the measurement of ROS production in living cells. The present
study therefore utilizes RNA interference to disrupt mitochon-CELL METABOLISM : JUNE 2005 · VOL. 1 · COPYRIGHT © 2005 ELSEVdrial function, overexpression of cellular antioxidant enzymes
to modify intracellular oxidant signals, and a novel redox-sensi-
tive FRET protein sensor to assess cytosolic oxidant signaling.
We show that a functional mitochondrial ETC is required for
hypoxia-induced ROS production and that this ROS pro-
duction is specifically required for hypoxia-induced HIF-α sta-
bilization.
Results
To determine whether the ETC is required for hypoxic stabiliza-
tion of HIF-1α, human 143B osteosarcoma cells were depleted
of mitochondrial DNA (King and Attardi, 1989). The resulting
ρ0 genotype is characterized by a lack of mitochondrial DNA
encoding a variety of genes located in diverse regions of the
mitochondrial genome (Figure 1B). Further characterization of
ρ0 cells is described in the accompanying Supplemental Data
available with this article online. The 143B ρ0 cells fail to stabi-
lize HIF-1α during hypoxia yet still respond to anoxia, which
blocks HIF-1α hydroxylation by depriving PHDs of substrate
(Schroedl et al., 2002) in a mitochondria-independent manner
(Figure 1A). Stabilization of HIF-1α in wild-type 143B cells is
inhibited by the complex I inhibitor rotenone. However, anoxic
activation of HIF-1α is insensitive to rotenone in both wild-type
and 143B ρ0 cells. Thus, a functional ETC is required for cellu-
lar sensing of hypoxia but is not required for HIF-1α stabiliza-
tion response to anoxic inhibition of PHDs.
To assess cytosolic ROS signaling, we introduce a novel flu-
orescence resonance energy transfer (FRET) sensor consisting
of cyan and yellow fluorescent proteins (CFP/YFP) linked by a
69 amino acid cysteine-containing regulatory domain from the
redox-regulated heat-shock protein HSP-33 (Jakob et al.,
1999). The resulting protein (HSP-FRET) was transiently ex-IER INC. DOI 10.1016/j.cmet.2005.05.001 401
S H O R T A R T I C L EFigure 1. Mitochondrial complex III is required for
hypoxic stabilization of HIF-1α
A) 143B ρ0 cells were generated by long-term expo-
sure to EtBr (50 ng/ml). The 143B wild-type (wt) and
ρ0 cells were exposed to 21%, 1%, or 0% O2 for 3
hr with or without rotenone (2.5 M). HIF-1α and
β-actin levels were analyzed from whole-cell ex-
tracts by immunoblotting.
B) Loss of mitochondrial DNA was confirmed in the
143B ρ0 cells by semiquantitative RT-PCR analysis
of mitochondrial genes in comparison to β-actin.
C) 143B wt and ρ0 cells were transfected with a
plasmid expressing the HSP-FRET probe and ex-
posed to hypoxia (1% O2). (Means ± SEM.)
D) 143B wt cells transfected with HSP-FRET were
incubated with stigmatellin (100 nM) and exposed
to 30 min of hypoxia (1% O2). (Means ± SEM.)
E) Hep3B cells exposed to hypoxia for 3 hr in the
presence of myxothiazol or stigmatellin. HIF-1α,
HIF-2α, and β-actin levels were analyzed from
whole-cell extracts by immunoblotting.
F) HEK293 and (G) Hep3B cells were transfected
with RNA hairpins complementary to RISP mRNA
(R1, R2, R8, R9) or random sequences (Mock).
Twenty-four hours after transfection, cells were se-
lected with puromycin (0.5 g/ml) for 7 days. Cells
were then exposed to 21% O2 (N), 1.5% O2 (H) or
100 M DFO (D) for 4 hr. Whole-cell extracts were
analyzed for levels of RISP, HIF-1α, and β-actin via
immunoblotting. Constructs producing significant
knockdown of RISP (R1, R8, and R9) significantly
attenuate HIF-1α responses to hypoxia.pressed in cells, permitting optical interrogation of cytosolic
thiol redox in live cells. Oxidation of cysteine thiols in the linker
domain causes separation of the CFP and YFP fluorophores,
increasing the CFP/YFP HSP-FRET ratio. Oxidation of HSP-
FRET occurs in response to exogenous H2O2 (Figure 4A) but
not during exposure to nitric oxide (500 nM; Figure S3A). How-
ever, hypoxia increases cytosolic oxidant signaling, as demon-
strated by a change in HSP-FRET ratio in 143B cells (Figure
1C). Administration of the thiol reductants 2 mercaptoproprio-
nyl glycine or pyrrolidine dithiocarbamate abrogate the HSP-
FRET response to hypoxia by maintaining thiols in a reduced
state (Figure S3B). Control studies using an empty FRET con-
struct in which the redox-sensitive domain is replaced by a402control peptide lacking cysteine residues fails to respond to
hypoxia. Using HSP-FRET, hypoxic responses in ρ0 cells are
significantly attenuated, indicating that oxidant signals during
hypoxia originate from the ETC (Figure 1C).
The majority of H2O2 detected during hypoxia by HSP-FRET
appears to originate from complex III of the ETC, since it is
attenuated by stigmatellin (Figure 1D), which inhibits electron
flux into complex III at the same site as myxothiazol. Myxothia-
zol and stigmatellin inhibit hypoxic stabilization of HIF-1α and
-2α in Hep3B cells (Figure 1E) and 143B wild-type cells (data
not shown) dose-dependently, but fail to inhibit HIF-α stabiliza-
tion in response to direct PHD inhibition with dimethyloxallyl
glycine (DMOG; data not shown). Therefore, a functional com-CELL METABOLISM : JUNE 2005
Mitochondrial complex III and HIF stabilizationplex III of the ETC is required for O2 sensing and HIF-α stabili-
zation through its involvement in ROS production.
While ρ0 cells provide insight into the role of mitochondria in
O2 sensing, other investigators report conflicting results (Vaux
et al., 2001). We therefore employed RNA interference to inhibit
expression of the Rieske iron-sulfur protein (RISP), which nor-
mally transfers an electron from ubiquinol to cytochrome c1 in
complex III (Link and Iwata, 1996). This oxidation produces a
ubisemiquinone radical, which may generate superoxide (Fig-
ure 4F). Genetic attenuation of RISP should therefore inhibit
ROS production at complex III.
Transient knockdown of RISP was achieved by transfection
with RNA hairpins complementary to RISP mRNA (R1, R8, R9)
or scrambled sequences (Mock) in HEK293 (Figure 1F) and
Hep3B cells (Figure 1G). After selection in puromycin for 7
days, heterogeneous populations of cells with knockdown of
RISP show an attenuated hypoxic stabilization of HIF-1α com-
pared with Mock cells, further supporting the proposed role of
complex III in the hypoxic response.
Subsequently, 143B cells were stably transfected with other
short-hairpin RNA (shRNA) oligonucleotides targeted to six dif-
ferent regions of human RISP mRNA (Figure S2A; Paddison et
al., 2002). We then isolated stable clones expressing shRNA
from those constructs. Significant heterogeneity in the extent
of RISP knockdown was observed among clonal populations
(Figure S2B). RISP shRNA clones demonstrated a highly spe-
cific knockdown of RISP compared to other proteins (Figure
2A) and significant reduction in O2 consumption (Figure S1A).
Further characterization of those cells is depicted in the ac-
companying Supplemental Data.
143B cells with stable knockdown of RISP achieved with two
different targeting constructs exhibit decreased ROS prod-
uction during hypoxia (Figure 2B) and decreased hypoxic stabi-
lization of HIF-1α (Figures 2C and S4B), compared with wild-
type controls. However, they retain responsiveness to the hyp-
oxic mimetics deferoxamine (DFO), cobalt chloride (CoCl2), and
DMOG (Figures 2C and 2D). While hypoxic HIF-1α stabilization
in wild-type 143B cells is inhibited by myxothiazol, the small
increase in HIF-1α retained during hypoxia in RISP shRNA
clones is insensitive to myxothiazol and appears to mimic the
wild-type response in the presence of myxothiazol (Figure 2D).
RISP shRNA clones also exhibit normal HIF-1α stabilization
during anoxia (Figure 2E). Overall, RISP shRNA clones show a
2.5- to 3-fold decrease in hypoxic HIF-1α stabilization but
maintain normal responses to DFO, CoCl2, DMOG, and anoxia
(Figure 2F), which appear to directly interfere with PHD activity.
Thus, loss of RISP and complex III activity selectively un-
dermines hypoxic sensitivity without abrogating the capacity
for HIF-1α stabilization in response to PHD inhibition, which is
proposed to act downstream from the O2 sensor. Furthermore,
RISP knockdown decreases hypoxia-induced ROS production,
strongly suggesting a link between ROS production from com-
plex III and HIF-1α stabilization.
To determine whether ROS is necessary for the response,
we tested whether antioxidants block hypoxic HIF-α stabiliza-
tion. The glutathione mimetic ebselen (Schewe, 1995) de-
creases hypoxia-induced HSP-FRET oxidation (Figure 3A) and
attenuates hypoxic HIF-1α and HIF-2α stabilization (Figure
3B). Furthermore, overexpression of catalase, which degrades
H O , was achieved using a recombinant adenovirus. Catalase2 2
CELL METABOLISM : JUNE 2005overexpression inhibits hypoxia-induced oxidation of HSP-
FRET (Figures 3C and S3B), indicating that HSP-FRET is sensi-
tive to changes in cytosolic thiol redox balance induced by
H2O2. However, overexpression of Cu,Zn-superoxide dismu-
tase (SOD-I) or Mn-superoxide dismutase (SOD-II), which con-
vert superoxide to H2O2, has no significant effect on hypoxia-
induced HSP-FRET oxidation (Figure 3D), suggesting that
HSP-FRET is oxidized by H2O2 rather than by superoxide. Cat-
alase overexpression reduces hypoxic stabilization of HIF-1α
(Figure 3E) and HIF-2α (data not shown) but does not affect
mitochondria-independent stabilization by DFO. Expression of
similar levels of catalase targeted to the mitochondrial matrix
has a only a small effect on hypoxic HIF-1α stabilization, sug-
gesting that H2O2 release to the cytosol is more important for
HIF-1 activation than is H2O2 release to the matrix. Overex-
pression of SOD-I or SOD-II failed to inhibit hypoxic stabiliza-
tion of HIF-1α (Figure 3E) or HIF-2α (data not shown). There-
fore, mitochondrial release of H2O2, but not superoxide, is
required for hypoxic stabilization of HIF-α, but not for stabiliza-
tion caused by direct PHD inhibition.
To determine whether exogenous H2O2 is sufficient to oxi-
dize HSP-FRET and to trigger HIF-α stabilization during nor-
moxia, glucose oxidase was administered to Hep3B cells in
order to generate H2O2 (Figure 4A). Either glucose oxidase (10
g/ml) or exogenous H2O2 (10–100 M; data not shown) can
oxidize HSP-FRET to the same degree as hypoxia. Doses of
H2O2 that oxidize HSP-FRET administered to Hep3B (Figure
4B) and HEK293 (data not shown) cells in serum-free media
cause normoxic stabilization of HIF-1α and HIF-2α. Moreover,
exogenous tert-butyl hydroperoxide administered to 143B ρ0
cells also elicits stabilization of HIF-1α during normoxia (Fig-
ure S4A).
Since exogenous H2O2 can stabilize HIF-1α independently
of mitochondria (Chandel et al., 2000), we tested whether RISP
shRNA clones exhibiting deficient hypoxic HIF-1α stabilization
retain the ability to stabilize HIF-1α in response to exogenous
H2O2. H2O2 (50 M; data not shown), tert-butyl hydroperoxide
(TBP; 10-100 M; Figure 4C), or glucose oxidase (10 g/ml;
Figure 4D), stabilize HIF-1α in normoxic wild-type and RISP
shRNA clones. During hypoxia, glucose oxidase produces only
a slight increase in HIF-1α stabilization in wild-type 143B cells.
However, in hypoxic RISP shRNA clones, glucose oxidase re-
stores HIF-1α stabilization to the level induced by hypoxia in
wild-type cells (Figure 4D). While hypoxic stabilization of HIF-
1α is not affected by addition of catalase to the cell-culture
medium, the effects of glucose oxidase can be inhibited with
extracellular catalase (200 U/ml; data not shown). These data
indicate that RISP is crucial for hypoxic stabilization of HIF-1α
due to its involvement in the generation of superoxide (Figure
4F), which is rapidly dismuted to the signaling molecule H2O2.
To test the effect of exogenous oxidants on hydroxylation
and subsequent ubiquitination of HIF-1α, we administered tert-
butyl hydroperoxide to Hep3B cells in the presence of the pro-
teasome inhibitor MG-132. Tert-butyl hydroperoxide stabilized
HIF-1α during normoxia, but it failed to abolish the accumula-
tion of ubiquitinated HIF-1α (Figure 4E). Similarly, treatment of
Hep3B cells with hypoxia or DMOG resulted in HIF-1α stabili-
zation without preventing accumulation of ubiquitinated HIF
(Figure 4E). By contrast, anoxia stabilized HIF-1α while it de-
creased ubiquitinated HIF levels significantly. Thus, inhibition
of PHD activity by 1% O or by administration of ROS during2
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S H O R T A R T I C L EFigure 2. Complex III RISP knockdown attenuates
hypoxic ROS production and stabilization of HIF-1α
A) 143B cells were transfected with a plasmid ex-
pressing RISP shRNA sequence 5. After 24 hr, cells
were selected with G418 (0.5 mg/ml) until stable
clones could be isolated. Whole-cell extracts from
143B RISP shRNA clones 5K and 5L were analyzed
for expression of β-actin, RISP, succinate dehydro-
genase subunit B (SdhB), cytochrome c, and SdhA
by immunoblotting.
B) 143B wt or RISP shRNA 5K cells transfected with
the HSP-FRET probe were exposed to hypoxia (1%
O2). (Means ± SEM.)
C) 143B wt and RISP shRNA 5K cells grown to 80%
confluence were exposed to normoxia (N), DFO (D;
100 M), CoCl2 (C; 100 M), or hypoxia (H; 1.5%
O2) for 3 hr.
D) 143B wt and RISP shRNA 5K cells were grown
as in (C) and exposed to hypoxia (H) in the presence
or absence of myxothiazol (M; 0.1 g/ml) for 2.5 hr.
DFO (D) was added as a positive control.
E) Immunoblots showing 143B wt and RISP shRNA
5K cells exposed to normoxia (N), hypoxia (H), an-
oxia (A), or DFO (D) for 3 hr.
F) HIF-1α immunoblots from numerous experiments
where wt and RISP shRNA 5K cells were exposed
to hypoxia (1.5% O2; n = 13), DFO (n = 7), CoCl2
(n = 3), DMOG (n = 3), and anoxia (n = 4) were quan-
tified via densitometric analysis and normalized to
β-actin. Data is presented as fold increase from nor-
moxia; *indicates a significant difference from wt
values (p = 0.01). (Means ± SEM.)normoxia is incomplete, such that accumulation of nonubiquiti-
nated HIF-1α can still continue, albeit to a lesser extent than
in normoxia. Inhibition of PHD activity by anoxia, however, is
sufficient to abolish the accumulation of ubiquitinated HIF due
to the inability to hydroxylate HIF-1α.
Discussion
Whether ROS production increases or decreases during hyp-
oxia has been a focus of debate, based on the behavior of
existing oxidant-sensitive probes (Chandel et al., 2000; Srini-
vas et al., 2001; Gorlach et al., 2003). Using a ratiometric sen-
sor, we find compelling evidence for increased H2O2 produc-
tion from mitochondria during hypoxia. This increase requires
electron transport in complex III, and it triggers HIF-α stabiliza-
tion during hypoxia. By contrast, HIF-α stabilization during
anoxia or in response to DMOG, DFO, or CoCl does not re-2
404quire mitochondria because these interventions directly inhibit
PHDs, thereby preventing recognition by VHL protein. Hence,
mitochondria act as O2 sensors during hypoxia, whereas PHDs
act as O2 sensors during anoxia. These characteristics assure
continued activation of HIF-mediated adaptive responses
when tissue hypoxia progresses to anoxia, when ROS produc-
tion presumably would halt.
Superoxide can be generated at the Qi or Qo sites in com-
plex III, resulting in ROS release to the matrix and/or the inter-
membrane space/cytosol (Figure 4F). Superoxide released to
the matrix from complex I or III is unlikely to escape to the
cytosol (Muller et al., 2004), although H2O2 formed in the matrix
could conceivably escape. Cytosolic catalase attenuates HSP-
FRET oxidation and abrogates HIF-α stabilization in hypoxia,
whereas HIF responses are preserved in cells expressing cata-
lase targeted to the matrix. This indicates that cytosolic, rather
than matrix, oxidant signals are required for hypoxic activationCELL METABOLISM : JUNE 2005
Mitochondrial complex III and HIF stabilizationFigure 3. Requirement of cytosolic H2O2 for hypoxic
stabilization of HIF-1α
A) Embryonic chick cardiomyocytes expressing
HSP-FRET were exposed to hypoxia (1% O2) with
or without ebselen (25 M). (Means ± SEM.)
B) Hep3B cells at 80% confluence were exposed
to hypoxia in the presence of ebselen. Whole-cell
extracts were analyzed for HIF-1α and HIF-2α by
immunoblotting.
C and D) Mouse embryonic culture EC cells were
transfected with HSP-FRET. Cells were infected
with the recombinant adenoviruses expressing cat-
alase (1000 pfu/cell; [C]) and SOD-I (100 pfu/cell) or
SOD-II (10 pfu/cell; [D]) 24 hr prior to the experi-
ment. (Means ± SEM.)
E) Mouse EC cells were infected with adenoviruses
expressing catalase, mitochondria-targeted cata-
lase (mito-Cat), SODI, or SOD-II for 24 hr. Then, the
media were changed and cells were exposed to
normoxia, hypoxia, or normoxia + DFO (D; 100 M)
for 2.5 hr. Overexpression of catalase, SOD-I, and
SOD-II were verified, and stabilization of HIF-1α
was analyzed via immunoblotting. NS: nonspecific
signal.of HIF-α. However, loss of complex III activity also disrupts
electron flux in complex I and II, so the possible involvement
of these systems cannot be excluded. Inhibition of complex III
would be expected to augment superoxide formation at I and/
or II, yet we observe a decrease in hypoxia-induced ROS for-
mation in response to myxothiazol, stigmatellin, and by genetic
depletion of RISP. These interventions block the oxidation of
ubiquinol to ubisemiquinone, prevent subsequent superoxide
production, and inhibit HIF-α stabilization in hypoxia. Our find-
ings implicate superoxide release from the Qo site of complex
III to the intermembrane space and subsequent H2O2 release
to the cytosol. The mechanism by which hypoxia increases
ROS generation at complex III is unknown, but it could involve
O2-dependent structural changes that prolong the lifetime of
ubisemiquinone, that increase accessibility of O2 to a site
where single electrons can be captured, or that alter the direc-
tional escape of superoxide to the intermembrane space ver-
sus matrix compartments (Muller et al., 2004).CELL METABOLISM : JUNE 2005Neither SOD I nor II overexpression abolishes HIF-α re-
sponses to hypoxia, indicating that superoxide is not directly
required, although undoubtedly it is the source of H2O2 during
hypoxia. Exogenous oxidants stabilize HIF-α during normoxia,
indicating a requirement for peroxide as a signaling agent. Ex-
ogenous oxidants also stabilize HIF in RISP knockdown cells
and in ρ0 cells, indicating that the ETC is not required for the
response to H2O2.
PHDs require O2 as a substrate, allowing the enzyme to
function as an O2 sensor in anoxia. We previously reported that
Hep3B ρ0 cells fail to stabilize HIF-1α in 1.5% O2, but this was
challenged when others reported that ρ0 cells retain HIF re-
sponses to anoxic conditions (<0.1% O2; Vaux et al., 2001).
We now clarify this issue by showing that, similar to data pre-
sented by Schroedl et al. (2002), ρ0 cells retain HIF responses
to anoxia while they lose the ability to increase ROS and stabi-
lize HIF-1α during hypoxia because they lack a functional ETC.
Furthermore, other genetic models in addition to the present405
S H O R T A R T I C L EFigure 4. Exogenous H2O2 is sufficient to oxidize
HSP-FRET and stabilize HIF-1α during normoxia
A) Hep3B cells expressing HSP-FRET. Glucose oxi-
dase (10 g/ml) was added to the perfusate to in-
duce H2O2 production. (Means ± SEM.)
B) Normoxic Hep3B cells were administered bo-
luses of H2O2 every 20 min or exposed to hypoxia
(H) for 2 hr, and HIF-1α, HIF-2α, and β-actin levels
were assessed via immunoblotting.
C) 143B wt and RISP shRNA 5K cells were incu-
bated in normoxia (N), hypoxia (H), or with CoCl2
(C) for 2 hr. Exogenous tert-butyl hydroperoxide was
applied as indicated every 20 min.
D) 143B wt and RISP shRNA 5K cells were incu-
bated with glucose oxidase for 2 hr in normoxia (N)
or hypoxia (H).
E) Hep3B cells were exposed to normoxia (N), hyp-
oxia (H), DMOG (DG), or anoxia (A) for 4 hr, and TBP
for 2 hr. MG-132 (10 M) was added to cells for the
last 1 hr.
F) Schematic diagram of mitochondrial complex III
illustrating sites of superoxide production believed
to be augmented during hypoxia.study independently demonstrate the significance of complex
III for hypoxic HIF-α stabilization (Mansfield et al., 2005 [this
issue of Cell Metabolism]; Brunelle et al., 2005 [this issue of
Cell Metabolism]).
We show that cells continue to hydroxylate and ubiquitinate
HIF-1α during hypoxia, during pharmacologic inhibition of
PHD, and in response to exogenous oxidants. The similar pat-
terns suggest that these interventions all cause HIF-α stabili-406zation by partially inhibiting PHD activity. By contrast, anoxia
abrogates the accumulation of ubiquitin-labeled HIF-1α, indi-
cating a complete inhibition of PHDs. These findings reveal that
mitochondrial oxidants regulate HIF-α responses during physi-
ological hypoxia. The regulation of PHD by oxidant signals is
poorly understood, and further studies are required to under-
stand the details of the signal transduction pathway linking
hypoxia-induced mitochondrial ROS to inhibition of PHDs.CELL METABOLISM : JUNE 2005
Mitochondrial complex III and HIF stabilization
AcknowledgmentsExperimental procedures
Cell culture and reagents
Hep3B, HEK293, and 143B cells were obtained from ATCC and maintained
in a humidified, 37°C, 5% CO2 incubator. Media were formulated according
to manufacturer’s recommendations. 143B ρ0 cells were generated by incu-
bating cells in media containing ethidium bromide (50 ng/ml) and supple-
mented with uridine (500 ug/ml) and pyruvate (2.5 mM). Cells were deter-
mined to be ρ0 based upon respiration phenotype and loss of a variety
of mitochondrial genes after a number of weeks. Rotenone, myxothiazol,
stigmatellin, ebselen, hydrogen peroxide, tert-butyl hydroperoxide, glucose
oxidase, DFO, and CoCl2 were purchased from Sigma Chemicals. MG-132
was obtained from EMD Biosciences. Recombinant adenoviruses express-
ing catalase and mitochondria-targeted catalase were kind gifts from Drs.
Cederbaum and Bai (Bai et al., 1999), and adenoviruses expressing SOD-I
and SOD-II were obtained from J.F. Engelhardt (Zwacka et al., 1998a;
Zwacka et al., 1998b).
RNA interference
RNAi for RISP used in HEK293T cells and Hep3B cells were generated by
selecting nine sequences (21–29 base pair-long, named R1–R9) with a G at
5# end and TT at 3# end that are unique for RISP. A PCR-based strategy
previously described (Fox et al., 2003) was used to generate U6-promoter
shRNA cassettes as well as a control Mock vector. Human 143B osteosar-
coma cells were electroporated with a pPNT or pPNT-shRNA vector (as
detailed in the accompanying Supplemental Data), and after 24 hr, cells
were selected with G418 (0.5 mg/ml). For short-term knockdown, cells were
selected for 7 days and collected to assess RISP knockdown via immu-
noblotting. Stable G418-resistant clones were maintained in media contain-
ing G418, uridine, and pyruvate until clonal colonies emerged, at which time
clones were collected. Clones generated from each of the six shRNA vec-
tors or the empty pPNT vector (wild-type) were screened via immunoblot-
ting for expression of RISP, and clones demonstrating significant knock-
down of RISP expression were further analyzed.
Hypoxia, anoxia, and exogenous oxidants
Hypoxic experiments were carried out in a Coy Laboratories hypoxic glove
box equilibrated to 1.5% O2, 5% CO2, and 93.5% N2. Experiments were
2–3 hr in length unless otherwise noted. Anoxic experiments were carried
out in an anoxic glove box equilibrated to 5% CO2, 3%–4% H2, balance
N2, where anoxia was maintained with the use of a palladium catalyst. Ex-
periments were 3 hr in length unless otherwise noted. Cells exposed to
exogenous H2O2 or tert-butyl hydroperoxide were incubated in normoxic
serum-free media, and boluses of oxidants were applied every 20 min for
2 hr. Cells exposed to glucose oxidase were incubated in serum-free media
throughout the experiment. All hypoxic and anoxic whole-cell extracts were
collected within the experimental workstations.
Western blotting
Whole-cell lysates were generated and analyzed via Western blot analysis
as described in the accompanying Supplemental Data.
Measurement of ROS
The HSP-FRET probe was created as described in the accompanying Sup-
plemental Data. Cells were plated on glass coverslips and transfected
(Geneporter, Gene Therapy Systems) with a plasmid encoding the HSP-
FRET probe expressed under the CMV promoter. The cells were then
placed in a flow-through chamber and mounted on an inverted epifluores-
cence microscope. Individual cells were monitored over time for their YFP
and CFP fluorescence, and the HSP-FRET ratio is defined as the YFP/CFP
fluorescence ratio in individual cells. Ratios were normalized to normoxic
baseline after 20 min of equilibration. Cells were perfused with a basic salt
solution bubbled with a 21% O2, 5% CO2, 74% N2 gas mixture. Hypoxia
was induced by bubbling with 0%–1% O2, 5% CO2, 96% N2 gas.
Supplemental data
Supplemental Data include four figures and Supplemental Experimental
Procedures and can be found with this article online at http://www.
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